Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging

详细信息    查看全文

• 作者：Man Kyu Shim ; Dr. Hong Yeol Yoon ; Dr. Ju Hee Ryu ; Dr. Heebeom Koo ; Dr. Sangmin Lee ; Dr. Jae Hyung Park ; Dr. Jong-Ho Kim ; Dr. Seulki Lee ; Dr. Martin G. Pomper ; Dr. Ick Chan Kwon and Dr. Kwangmeyung Kim
• 刊名：Angewandte Chemie
• 出版年：2016
• 出版时间：November 14, 2016
• 年：2016
• 卷：128
• 期：47
• 页码：14918-14923
• 全文大小：4810K
• ISSN：1521-3757

文摘

Recently, metabolic glycoengineering with bioorthogonal click reactions has focused on improving the tumor targeting efficiency of nanoparticles as delivery vehicles for anticancer drugs or imaging agents. It is the key technique for developing tumor-specific metabolic precursors that can generate unnatural glycans on the tumor-cell surface. A cathepsin B-specific cleavable substrate (KGRR) conjugated with triacetylated N-azidoacetyl-d-mannosamine (RR-S-Ac₃ManNAz) was developed to enable tumor cells to generate unnatural glycans that contain azide groups. The generation of azide groups on the tumor cell surface was exogenously and specifically controlled by the amount of RR-S-Ac₃ManNAz that was fed to target tumor cells. Moreover, unnatural glycans on the tumor cell surface were conjugated with near infrared fluorescence (NIRF) dye-labeled molecules by a bioorthogonal click reaction in cell cultures and in tumor-bearing mice. Therefore, our RR-S-Ac₃ManNAz is promising for research in tumor-specific imaging or drug delivery.